Showing results (1161-1170 of 1,188) with videos related to

Sort By:
Pageof 119
Nature Communications|August 30, 2025
Temporal dynamics and microbial interactions shaping the gut resistome in early infancyIoanna Chatzigiannidou, Pi L Johansen, Rasmus K Dehli, et al.
Stem Cells and Development|September 10, 2016
Propagating Humanized BLT Mice for the Study of Human Immunology and ImmunotherapyDrake J Smith, Levina J Lin, Heesung Moon, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2018
Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC moleculesMichael T Bethune, Xiao-Hua Li, Jiaji Yu, et al.
Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.
Nature Biomedical Engineering|October 25, 2024
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 studyRobert T Naismith, Jerry S Wolinsky, Annette Wundes, et al.
EMBO Reports|April 19, 2022
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factorsZhiwu Jiang, Lin Cheng, Zhiping Wu, et al.
Nature Communications|May 12, 2023
High-throughput single nucleus total RNA sequencing of formalin-fixed paraffin-embedded tissues by snRandom-seqZiye Xu, Tianyu Zhang, Hongyu Chen, et al.
Frontiers in Immunology|December 29, 2025
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategyHongye Tan, Noor Ul Huda Shah, Bingjia He, et al.
Pageof 119